These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 25428)

  • 1. Rate of bronchodilatation with rimiterol aerosol.
    Freedman BJ
    Practitioner; 1978 Mar; 220(1317):476-8. PubMed ID: 25428
    [No Abstract]   [Full Text] [Related]  

  • 2. The relative potencies and beta2-selectivities of intravenous rimiterol, salbutamol and isoprenaline in asthmatic patients.
    Marlin GE; Turner P
    Int J Clin Pharmacol Biopharm; 1975 Jul; 12(1-2):158-69. PubMed ID: 240780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of rimiterol and salbutamol by inhalation at high and low dose in asthmatic patients.
    Muittari A
    Respiration; 1978; 35(3):165-72. PubMed ID: 25466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of cardiorespiratory effects of rimiterol and terbutaline aerosols.
    Harris L
    Bull Physiopathol Respir (Nancy); 1974; 10(6):801-10. PubMed ID: 4156915
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of intravenous injection of rimiterol in asthma.
    Tarala RA; Martyn V; Paterson JW
    Br J Clin Pharmacol; 1981 Sep; 12(3):333-40. PubMed ID: 6117302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative potencies and beta2-adrenoreceptor selectivities of rimiterol and salbutamol aerosols.
    Marlin GE; Hartnett BJ; Berend N
    Br J Clin Pharmacol; 1977 Feb; 4(1):77-9. PubMed ID: 14660
    [No Abstract]   [Full Text] [Related]  

  • 7. Further studies of rimiterol and salbutamol administered by intermittent positive-pressure ventilation, and an important observation on the technique of using the Bennett ventilator.
    Paterson IC; Willey RF; Shotter MV; Crompton GK
    Br J Clin Pharmacol; 1977 Oct; 4(5):605-9. PubMed ID: 20919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison between the bronchodilator and cardiovascular effects of inhaling 0.5 mg. rimiterol ('Pulmadil') and 0.2 mg. salbutamol.
    Bianco S; Kamburoff PL; Prime FJ
    Curr Med Res Opin; 1975; 3(1):30-5. PubMed ID: 1116382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The acute effects of the administration of rimiterol aerosol in asthmatic children.
    Blackhall MI; Macartney B; O'Donnell SR
    Br J Clin Pharmacol; 1978 Jul; 6(1):59-62. PubMed ID: 27205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of histamine induced bronchoconstriction as a method for investigating bronchodilator drugs.
    Kamburoff PL; Griffin JP; Bianco S
    Br J Dis Chest; 1972 Jan; 66(1):21-6. PubMed ID: 4552967
    [No Abstract]   [Full Text] [Related]  

  • 11. Rimiterol: a review of its pharmacological properties and therapeutic efficacy in asthma.
    Pinder RM; Brogden RN; Speight TM; Avery GS
    Drugs; 1977 Aug; 14(2):81-104. PubMed ID: 19226
    [No Abstract]   [Full Text] [Related]  

  • 12. The rapidity of bronchodilatation. A comparison of isoprenaline, terbutaline and rimiterol.
    Eriksson NE; Lindgren SB
    Scand J Respir Dis; 1978 Feb; 59(1):30-6. PubMed ID: 26113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous treatment with rimiterol and salbutamol in asthma.
    Marlin GE; Turner P
    Br Med J; 1975 Jun; 2(5973):715-9. PubMed ID: 1139193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained release aminophylline in asthma and its interaction with rimiterol.
    Monie RD; Rocchiccioli KM; White JP
    Br J Clin Pharmacol; 1982 Jul; 14(1):110-2. PubMed ID: 6125198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of a new adrenergic beta 2 -receptor-stimulating agent (rimiterol, R798) in patients with chronic obstructive lung disease.
    Svedmyr N; Malmberg R; Thiringer G
    Scand J Respir Dis; 1972; 53(5):302-13. PubMed ID: 4404808
    [No Abstract]   [Full Text] [Related]  

  • 16. Assessment of combined oral theophylline and inhaled beta-adrenoceptor agonist bronchodilator therapy.
    Marlin GE; Hartnett BJ; Berend N; Hacket NB
    Br J Clin Pharmacol; 1978 Jan; 5(1):45-50. PubMed ID: 23134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A brief review of sympathomimetic bronchodilators and a description of a new selective agent, rimiterol hydrobromide.
    Muittari A
    Respiration; 1978; 35(3):173-80. PubMed ID: 25467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new bronchodilator, rimiterol hydrobromide (R 798): an open study of the bronchodilator, cardiovascular and arterial oxygen changes in asthmatic patients.
    Linehan WD
    Ir J Med Sci; 1975 Apr; 144(4):144-56. PubMed ID: 238916
    [No Abstract]   [Full Text] [Related]  

  • 19. Proceedings: The pharmokinetics of rimiterol in asthmatic patients.
    Evans ME; Paterson JW; Shenfield GM; Thomas N; Walker SR
    Br J Pharmacol; 1973 Sep; 49(1):153P-154P. PubMed ID: 4150761
    [No Abstract]   [Full Text] [Related]  

  • 20. [Non-specific bronchial provocation tests in asthma (author's transl)].
    Orehek J; Gayrard P
    Bull Eur Physiopathol Respir; 1976; 12(4):565-98. PubMed ID: 797411
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.